Akanda Corp.
AKAN- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001888014
No open-market purchases or sales by Akanda Corp. insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $3.02K in total; no superinvestor holds it.
Holders of 5% or more of AKAN
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Akanda Corp., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Akanda Corp. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
6 Schedule 13D and 13G filings on Akanda Corp., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 20, 2024 | Halo Collective Inc. | 13D/AOld format | – | – | – | SEC |
| Feb 20, 2024 | Halo Collective Inc. | 13DOld format | – | – | – | SEC |
| Feb 20, 2024 | Halo Collective Inc. | 13G/AOld format | – | – | – | SEC |
| Oct 25, 2023 | Su Wilson | 13GOld format | – | New | – | SEC |
| Feb 15, 2023 | Halo Collective Inc. | 13GOld format | – | New | – | SEC |
| Jan 9, 2023 | 1306077 B.C. Ltd. | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
2 notices from officers, directors and other affiliates planning to sell Akanda Corp. shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| May 16, 20235:39 PM ET | Halo Collective Inc.10% stockholder | 492.2K | $541.3K | May 5, 2023 | Research Capital Corp. | SEC |
| Feb 8, 202311:56 AM ET | Halo Collective Inc.10% stockholder | 7.75M | $1.98M | Feb 7, 2023 | Research Capital Corp. | SEC |